7Baggers
 bristol myers to acquire rayzebio for $62.50 per share in cash  TipRanks Wed, 16 Apr 2025 03:24:02 GMT
 Neuroendocrine tumors Pipeline Analysis and Clinical Trials  openPR.com Wed, 09 Apr 2025 07:00:00 GMT
 extensive-stage small cell lung cancer (esclc) clinical  openPR.com Mon, 24 Mar 2025 15:56:00 GMT
 robust growth in neuroendocrine tumors market (2025-2032):  openPR Thu, 06 Mar 2025 09:30:00 GMT
 Radiopharmaceutical trials face extra complexities due to nuclear red tape  Clinical Trials Arena Fri, 29 Nov 2024 08:00:00 GMT
 william blair downgrades rayzebio (ryzb)  MSN Wed, 20 Nov 2024 20:58:44 GMT
 bristol raises guidance on demand for eliquis, new drugs  BNN Bloomberg Thu, 31 Oct 2024 07:00:00 GMT
 RayzeBio: A Christmas to remember  BioXconomy Wed, 25 Sep 2024 07:00:00 GMT
 RayzeBio, Dice alums raise $370 million for new autoimmune startup  statnews.com Mon, 09 Sep 2024 07:00:00 GMT
 Updated: Bristol Myers restarts radiopharmaceutical Phase 3 trial  Endpoints News Mon, 29 Jul 2024 07:00:00 GMT
 bristol myers raises profit forecast on drug demand  BNN Bloomberg Fri, 26 Jul 2024 07:00:00 GMT
 bms' dealmaking appetite remains intact, ceo says  FiercePharma Wed, 12 Jun 2024 07:00:00 GMT
 BMS, RayzeBio halt radiotherapy trial due to isotope shortage  TechTarget Wed, 05 Jun 2024 07:00:00 GMT
 RayzeBio warned of potential isotope supply issues before BMS deal  Endpoints News Wed, 05 Jun 2024 07:00:00 GMT
 supply constraints force pause of bms, rayzebio cancer study  FiercePharma Mon, 03 Jun 2024 07:00:00 GMT
 bristol myers posts quarterly loss, revenue rises 5%  MSN Fri, 17 May 2024 21:29:11 GMT
 biotech acquisition trend: radiopharmaceuticals  Taylor Wessing Wed, 08 May 2024 07:00:00 GMT
 bristol myers squibb to participate in upcoming investor conferences  Business Wire Tue, 07 May 2024 07:00:00 GMT
 bristol-myers squibb to buy rayzebio for $4.1 billion  MSN Tue, 07 May 2024 05:08:17 GMT
 novartis pays peptidream $180m as radiopharma big bang continues  Fierce Biotech Tue, 30 Apr 2024 07:00:00 GMT
 bristol myers posts quarterly loss, revenue rises 5%  WTAQ Thu, 25 Apr 2024 07:00:00 GMT
 pharmaceutical technology  Pharmaceutical Technology Wed, 27 Mar 2024 23:52:59 GMT
 citigroup inc. invests $553000 in rayzebio, inc. (nasdaq:ryzb)  Defense World Sat, 23 Mar 2024 08:35:48 GMT
 why fusion pharma is the latest billion dollar big pharma buy in radiopharmaceuticals  Life Science Leader Magazine Fri, 22 Mar 2024 07:00:00 GMT
 lianbio (nasdaq:lian) and rayzebio (nasdaq:ryzb) critical analysis  Defense World Thu, 21 Mar 2024 07:15:39 GMT
 Ben Hickey  Bristol Myers Squibb Thu, 14 Mar 2024 15:11:50 GMT
 rayzebio ipo, an overview  Cantech Letter Mon, 04 Mar 2024 08:00:00 GMT
 bristol myers squibb acquires majority stake in rayzebio for $4.1 billion  DOTmed HealthCare Business News Fri, 01 Mar 2024 08:00:00 GMT
 bristol myers squibb acquires rayzebio for $4.1bn  MSN Fri, 01 Mar 2024 04:14:08 GMT
 bms bolsters oncology portfolio with $4.1bn rayzebio buy  BioProcess Insider Thu, 29 Feb 2024 12:29:10 GMT
 Andreas Halvorsen's Firm Sells Out of RayzeBio Inc  GuruFocus Thu, 29 Feb 2024 08:00:00 GMT
 andreas halvorsen's firm sells out of rayzebio inc  Yahoo Finance Wed, 28 Feb 2024 08:00:00 GMT
 bristol myers completes acquisition of rayzebio  TipRanks Tue, 27 Feb 2024 14:24:33 GMT
 bristol myers completes acquisition of rayzebio - tipranks.com  TipRanks Tue, 27 Feb 2024 14:24:33 GMT
 Bristol Myers Squibb acquires RayzeBio for $4.1bn  Pharmaceutical Technology Tue, 27 Feb 2024 08:00:00 GMT
 Bristol Myers Squibb Acquire RayzeBio for $4.1 Billion  European Pharmaceutical Manufacturer Tue, 27 Feb 2024 08:00:00 GMT
 Big deals confirm renewed interest in radiopharmaceuticals | Business  Chemistry World Tue, 27 Feb 2024 08:00:00 GMT
 bristol myers squibb concludes acquisition of rayzebio  Medical Dialogues Tue, 27 Feb 2024 08:00:00 GMT
 pharmaceutical technology  Pharmaceutical Technology Tue, 27 Feb 2024 08:00:00 GMT
 rayzebio, inc. completes merger and delists from nasdaq  TipRanks Mon, 26 Feb 2024 08:00:00 GMT
 bristol myers completes acquisition of rayzebio  TipRanks Mon, 26 Feb 2024 08:00:00 GMT
 ben hickey  Bristol Myers Squibb Mon, 26 Feb 2024 08:00:00 GMT
 bristol myers squibb completes rayzebio acquisition by investing.com  Investing.com Mon, 26 Feb 2024 08:00:00 GMT
 bristol myers completes acquisition of rayzebio - tipranks.com  TipRanks Mon, 26 Feb 2024 08:00:00 GMT
 bms bolsters oncology portfolio with $4.1bn rayzebio buy  BioProcess Insider Mon, 26 Feb 2024 08:00:00 GMT
 Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer  Business Wire Fri, 23 Feb 2024 08:00:00 GMT
 bristol myers squibb nears rayzebio acquisition completion by investing.com  Investing.com Australia Fri, 23 Feb 2024 08:00:00 GMT
 bristol myers wraps rayzebio tender offer with 86% of shares  MarketWatch Fri, 23 Feb 2024 08:00:00 GMT
 rayzebio (nasdaq:ryzb) sets new 52-week high at $62.42  Defense World Fri, 16 Feb 2024 10:59:10 GMT
 rayzebio (nasdaq:ryzb) reaches new 12-month high at $62.42  MarketBeat Thu, 15 Feb 2024 00:22:48 GMT
 rayzebio (nasdaq:ryzb) reaches new 12-month high at $62.42  MarketBeat Wed, 14 Feb 2024 16:08:20 GMT
 bristol myers is tapping us high-grade bond market to fund m&a  Bloomberg Wed, 14 Feb 2024 08:00:00 GMT
 bristol myers sees over $85 billion of demand for m&a bond sale  Bloomberg Wed, 14 Feb 2024 08:00:00 GMT
 bayer ups its ante in radiopharma, signing on with pantera  FiercePharma Wed, 14 Feb 2024 08:00:00 GMT
 bristol myers squibb to acquire rayzebio for $4.1 billion by investing.com  Investing.com Nigeria Tue, 13 Feb 2024 09:28:14 GMT
 shareholder update: halper sadeh llc investigates door, zfox, ryzb  InvestorsObserver Mon, 12 Feb 2024 17:15:00 GMT
 brodsky & smith shareholder update: notifying investors of  GlobeNewswire Mon, 12 Feb 2024 08:00:00 GMT
 bristol myers squibb to acquire rayzebio for $4.1 billion  Investing.com Mon, 12 Feb 2024 08:00:00 GMT
 industry veterans launch new biotech vc with $310m  STAT Wed, 07 Feb 2024 08:00:00 GMT
 shareholder notice: halper sadeh llc investigates ryzb, fgh, axnx, amam  Marketscreener.com Tue, 30 Jan 2024 04:03:03 GMT
 2024-01-26 | nyse:bmy | press release | bristol-myers squibb co  Stockhouse Publishing Sat, 27 Jan 2024 03:18:59 GMT
 how bms won a ten-day, three-way race to snap up rayzebio  Scrip Thu, 25 Jan 2024 21:57:38 GMT
 RayzeBio drew other pharma interest before Bristol Myers deal  BioPharma Dive Thu, 25 Jan 2024 08:00:00 GMT
 shareholder notice: halper sadeh llc investigates krtx, ryzb, via  Marketscreener.com Tue, 23 Jan 2024 19:46:07 GMT
 2024-01-16 | ndaq:cstr | press release | capstar financial holdings inc  Stockhouse Publishing Tue, 16 Jan 2024 23:33:41 GMT
 Radiopharmaceuticals garner continued M&A investments  Nature Mon, 15 Jan 2024 08:00:00 GMT
 2024-01-08 | nyse:cpe | press release | callon petroleum co  Stockhouse Publishing Mon, 08 Jan 2024 22:13:12 GMT
 at jpm, ceo boerner says bms is set to grow by end of the decade  FiercePharma Mon, 08 Jan 2024 08:00:00 GMT
 kuehn law encourages krtx, dske, ryzb, and grcl investors to contact law firm  Marketscreener.com Mon, 08 Jan 2024 08:00:00 GMT
 bristol myers squibb acquires rayzebio in $4.1bn deal — financier worldwide  Financier Worldwide Thu, 04 Jan 2024 12:55:40 GMT
 shareholder investigation : halper sadeh llc investigates ryzb, krtx, grcl  Marketscreener.com Thu, 04 Jan 2024 08:01:03 GMT
 advancell appoints anna karmann, md, phd as chief medical officer  Business Wire Thu, 04 Jan 2024 08:00:00 GMT
 billion-dollar bms: how (and why) pharma company is spending big  ROI-NJ.com Tue, 02 Jan 2024 08:00:00 GMT
 bristol myers squibb to acquire rayzebio  citybiz Mon, 01 Jan 2024 08:00:00 GMT
 bristol myers squibb acquires rayzebio  San Diego Business Journal Mon, 01 Jan 2024 08:00:00 GMT
 shareholder investigation : halper sadeh llc investigates ryzb, krtx, grcl  Marketscreener.com Sun, 31 Dec 2023 20:14:59 GMT
 bristol myers squibb to acquire rayzebio for $4.1 billion in cash  domain-b.com: The first online Indian business magazine Sun, 31 Dec 2023 08:00:00 GMT
 rayzebio  BioSpace Sat, 30 Dec 2023 22:53:19 GMT
 bristol myers squibb's big buys: $18.1 billion in 2 biotech deals  MarketBeat Fri, 29 Dec 2023 08:00:00 GMT
 Bristol-Myers Squibb Acquires RayzeBio  Powder & Bulk Solids Thu, 28 Dec 2023 17:24:45 GMT
 bristol myers squibb announces third m&a deal this year  The Pharma Letter Thu, 28 Dec 2023 08:00:00 GMT
 bristol-myers squibb to buy rayzebio for $4.1b  HealthLeaders Media Thu, 28 Dec 2023 08:00:00 GMT
 bristol myers to buy cancer drug developer rayzebio  Cheddar Thu, 28 Dec 2023 05:09:33 GMT
 bristol myers squibb to buy cancer drug developer rayzebio  Cheddar Thu, 28 Dec 2023 05:09:33 GMT
 bristol to buy drug developer rayzebio for $4.1 billion  MSN Wed, 27 Dec 2023 11:30:44 GMT
 Bristol Myers Squibb Acquires RayzeBio  Contract Pharma Wed, 27 Dec 2023 08:00:00 GMT
 Bristol Myers Squibb agrees to acquire RPT company RayzeBio for $4.1bn  Pharmaceutical Technology Wed, 27 Dec 2023 08:00:00 GMT
 BMS strikes again, with $4.1bn RayzeBio takeover bid  pharmaphorum Wed, 27 Dec 2023 08:00:00 GMT
 five things for pharma marketers to know on wednesday  MM+M Online Wed, 27 Dec 2023 08:00:00 GMT
 bristol myers to buy cancer drug developer rayzebio  Cheddar Wed, 27 Dec 2023 08:00:00 GMT
 bristol myers squibb goes back to the acquisition well with $4.1b purchase of rayzebio  Proactive Investors Australia Wed, 27 Dec 2023 08:00:00 GMT
 midday movers: intel, rayzebio, and more by investing.com  Investing.com Australia Wed, 27 Dec 2023 08:00:00 GMT
 bristol myers (bmy) to buy cancer drug-maker rayzebio for $4.1b  Yahoo Finance Wed, 27 Dec 2023 08:00:00 GMT
 bristol myers squibb agrees to acquire rayzebio for $4.1bn  Pharmaceutical Technology Wed, 27 Dec 2023 08:00:00 GMT
 trending tickers: intel | tencent | rayzebio | astrazeneca  Yahoo Finance UK Wed, 27 Dec 2023 08:00:00 GMT
 bristol myers squibb to buy cancer drug developer rayzebio  Cheddar Wed, 27 Dec 2023 08:00:00 GMT
 company news for dec 27, 2023  Yahoo Finance Wed, 27 Dec 2023 08:00:00 GMT
 bristol myers squibb to acquire rayzebio for $4.1b  LabPulse Wed, 27 Dec 2023 08:00:00 GMT
 william blair downgrades rayzebio (ryzb)  MSN Wed, 27 Dec 2023 08:00:00 GMT
 rayzebio takes short trip from ipo to buyout  Barron's Wed, 27 Dec 2023 01:01:00 GMT
 shareholder investigation : halper sadeh llc investigates grcl, ryzb, brbs  Marketscreener.com Tue, 26 Dec 2023 20:22:03 GMT
 fusion pharma gains on bristol myers-rayzebio deal  XM Tue, 26 Dec 2023 19:27:16 GMT
 sector update: health care -december 26, 2023 at 01:38 pm est  Marketscreener.com Tue, 26 Dec 2023 18:38:07 GMT
 rayzebio (nasdaq:ryzb) downgraded by william blair  MarketBeat Tue, 26 Dec 2023 15:59:51 GMT
 Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion  WSJ Tue, 26 Dec 2023 08:00:00 GMT
 Bristol Myers' $4.1 Billion Deal For RayzeBio Sends RYZB Stock Soaring 100%  Investor's Business Daily Tue, 26 Dec 2023 08:00:00 GMT
 BMS enters radiopharmaceutical space with $4.1 billion RayzeBio takeout  FirstWord Pharma Tue, 26 Dec 2023 08:00:00 GMT
 RayzeBio Takes Short Trip From IPO to Buyout  Barron's Tue, 26 Dec 2023 08:00:00 GMT
 Bristol Myers will pay $4.1 billion for cancer startup RayzeBio  statnews.com Tue, 26 Dec 2023 08:00:00 GMT
 Bristol Myers to buy RayzeBio for about $4.1B  Fox Business Tue, 26 Dec 2023 08:00:00 GMT
 Stock Market Today  Barron's Tue, 26 Dec 2023 08:00:00 GMT
 bristol myers to acquire rayzebio for $62.50 per share in cash  TipRanks Tue, 26 Dec 2023 08:00:00 GMT
 rayzebio: new ipo with good data and solid premise (nasdaq:ryzb)  Seeking Alpha Tue, 26 Dec 2023 08:00:00 GMT
 bristol myers buys rayzebio for $4.1b in latest deal  themiddlemarket.com Tue, 26 Dec 2023 08:00:00 GMT
 stocks to watch tuesday: manchester united, gracell, rayzebio, intel, apple  The Wall Street Journal Tue, 26 Dec 2023 08:00:00 GMT
 rayzebio to be acquired by bristol myers squibb for $4.1b  Inside INdiana Business Tue, 26 Dec 2023 08:00:00 GMT

RayzeBio Inc
(NASDAQ:RYZB) 

RYZB stock logo

RayzeBio is a clinical-stage radiopharmaceutical therapeutics (“RPT”) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs.

Founded: 2020
CEO: Dr. Kenneth Song  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends